We found that Meg3 levels were decreased in tumor tissues from CRC patients (Supplementary Fig. 1b), as well as in AOM/DSS-induced CRC mice (Supplementary Fig. 1c), compared to the corresponding control tissues. The gene discussed is MEG3; the disease is colorectal carcinoma.